医療薬学
Online ISSN : 1882-1499
Print ISSN : 1346-342X
ISSN-L : 1346-342X
一般論文
糖尿病を合併した造血器悪性腫瘍患者に対するステロイド療法時の‌血糖管理:
共同薬物治療管理下での薬剤師による処方支援の有用性
土手 賢史澤井 麻記服部 武志野崎 歩小林 由佳土井 章一新宮 とし子中西 弘和
著者情報
ジャーナル フリー

2013 年 39 巻 7 号 p. 395-405

詳細
抄録

The influence of pharmacist-supported insulin therapy on the safety and efficacy of blood glucose management in steroid therapy for hematologic malignancies complicated by diabetes in collaborative drug therapy management was examined. At the same time, an insulin dose-predicting factor required for blood glucose control was investigated. Changes in the blood glucose level after steroid administration were significantly decreased on medication support by a pharmacist compared to those in blood glucose control performed by a physician alone: the median (range) blood glucose level before breakfast, 138.6 (99.00 - 189.0) mg/dL vs 156.4 (111.2 - 204.6) mg/dL (P = 0.13); before lunch, 198.5 (128.7 - 307.0) mg/dL vs 240.9 (157.7 - 410.5) mg/dL (P < 0.01); before supper, 232.9 (161.7 - 329.8) mg/dL vs 311.5 (157.4 - 387.9) mg/dL (P < 0.01); before sleep, 247.5 (164.9 - 338.7) mg/dL vs 293.3 (174.7 - 345.9) mg/dL (P < 0.01), respectively. An index of daily glycemia excursions, Schlichtkrull M120 value, was also significantly decreased: 30.27 (5.96 - 66.04) vs 58.63 (9.21 - 93.68) (P < 0.001), respectively. The insulin dose was inversely correlated with the prednisolone dose (correlation coefficient: -0.511. P = 0.021), but no correlation with any other factor (dexamethasone dose, age, body mass index, and HbA1c (JDS ) was noted. The findings suggest that meticulous dose control in consideration of a patient’s insulin sensitivity is essential for blood glucose control using insulin in steroid therapy, and cooperation between pharmacists and physicians facilitates precise blood glucose control, leading to safe and effective insulin therapy.

著者関連情報
© 2013 日本医療薬学会
次の記事
feedback
Top